• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

bcl-2基因在许多弥漫性B细胞淋巴瘤中发生重排。

The bcl-2 gene is rearranged in many diffuse B-cell lymphomas.

作者信息

Aisenberg A C, Wilkes B M, Jacobson J O

机构信息

Department of Medicine, Massachusetts General Hospital, Boston 02114.

出版信息

Blood. 1988 Apr;71(4):969-72.

PMID:2965608
Abstract

Southern blotting was used to detect rearrangement of the bcl-2 gene in 104 cases of non-Hodgkin's lymphoma subclassified by the Working Formulation, 24 cases of B cell chronic lymphocytic leukemia (B-CLL) and 14 cases of T cell malignancy. Earlier workers reported rearrangement of this gene (located on chromosome 18) in a major fraction of follicular lymphomas, lymphomas in which a 14;18 chromosome translocation is frequently observed. In the present study, bcl-2 was rearranged in 30% (11 of 37) of follicular lymphomas and 19% (11 of 58) of diffuse lymphomas of follicle center cell lineage. In 18 of 19 samples studied, the rearranged bcl-2 fragment also hybridized with a probe for the joining region of the immunoglobulin heavy chain gene located on chromosome 14, indicating a 14;18 translocation. In lymphomas not derived from follicle center cells, ie, diffuse lymphomas of small B lymphocytes, B-CLL and T cell neoplasms, the bcl-2 gene was always in germline configuration. The frequent rearrangement of bcl-2 in a variety of B cell lymphomas of diffuse morphology (small cleaved cell, large cell, small noncleaved cell and immunoblastic) is noteworthy.

摘要

采用Southern印迹法检测了按照工作分类法分类的104例非霍奇金淋巴瘤、24例B细胞慢性淋巴细胞白血病(B-CLL)和14例T细胞恶性肿瘤中bcl-2基因的重排情况。早期研究人员报道,在大部分滤泡性淋巴瘤中该基因(位于18号染色体)发生重排,而在这类淋巴瘤中经常观察到14;18染色体易位。在本研究中,30%(37例中的11例)的滤泡性淋巴瘤和19%(58例中的11例)的滤泡中心细胞系弥漫性淋巴瘤中bcl-2发生重排。在研究的19个样本中的18个中,重排的bcl-2片段也与位于14号染色体上的免疫球蛋白重链基因连接区的探针杂交,表明存在14;18易位。在非滤泡中心细胞来源的淋巴瘤中,即小B淋巴细胞弥漫性淋巴瘤、B-CLL和T细胞肿瘤中,bcl-2基因总是处于种系构型。值得注意的是,在各种弥漫性形态的B细胞淋巴瘤(小裂细胞型、大细胞型、小无裂细胞型和免疫母细胞型)中bcl-2频繁重排。

相似文献

1
The bcl-2 gene is rearranged in many diffuse B-cell lymphomas.bcl-2基因在许多弥漫性B细胞淋巴瘤中发生重排。
Blood. 1988 Apr;71(4):969-72.
2
bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.bcl-1重排。B细胞慢性淋巴细胞白血病和非霍奇金淋巴瘤中的频率及临床意义。
Am J Pathol. 1991 Mar;138(3):591-9.
3
Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.非霍奇金淋巴瘤和慢性淋巴细胞白血病中Bcl-2重排,其断点位于vcr和mbr。
Br J Haematol. 1996 Mar;92(3):647-52. doi: 10.1046/j.1365-2141.1996.00388.x.
4
Variable rate of detection of immunoglobulin heavy chain V-D-J rearrangement by PCR: a systematic study of 41 B-cell non-Hodgkin's lymphomas and leukemias.通过聚合酶链反应检测免疫球蛋白重链V-D-J重排的可变率:对41例B细胞非霍奇金淋巴瘤和白血病的系统研究
Leuk Lymphoma. 1992 Jul;7(4):289-95. doi: 10.3109/10428199209049780.
5
Translocation t(14;18) in B cell lymphomas as a cause for defective immunoglobulin production.B细胞淋巴瘤中的14号与18号染色体易位是免疫球蛋白产生缺陷的一个原因。
J Exp Med. 1989 Mar 1;169(3):613-24. doi: 10.1084/jem.169.3.613.
6
Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma.与非霍奇金淋巴瘤临床转化相关的连续bcl-2和c-myc癌基因重排
J Clin Invest. 1989 Nov;84(5):1454-9. doi: 10.1172/JCI114320.
7
Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes.中心细胞淋巴瘤中11号染色体bcl-1基因座重排:用多个断点探针进行分析
Blood. 1991 Jul 15;78(2):493-8.
8
Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms.B细胞肿瘤中17号染色体q22区域BCL-3基因座的分子分析。
Blood. 1993 Sep 15;82(6):1813-9.
9
Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma.伴有t(8;14)和t(14;18)易位的前B细胞白血病之前会出现滤泡性淋巴瘤。
Oncogene. 1988 May;2(5):431-5.
10
Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.恶性淋巴瘤中t(14;18)染色体易位的分子分析。
N Engl J Med. 1987 Nov 5;317(19):1185-9. doi: 10.1056/NEJM198711053171904.

引用本文的文献

1
Tipping Growth Inhibition into Apoptosis by Combining Treatment with MDM2 and WIP1 Inhibitors in p53 Uterine Leiomyosarcoma.在p53子宫平滑肌肉瘤中联合使用MDM2和WIP1抑制剂将生长抑制转变为凋亡
Cancers (Basel). 2021 Dec 21;14(1):14. doi: 10.3390/cancers14010014.
2
EZH2/Bcl-2 Coexpression Predicts Worse Survival in Diffuse Large B-cell Lymphomas and Demonstrates Poor Efficacy to Rituximab in Localized Lesions.EZH2与Bcl-2共表达预示弥漫性大B细胞淋巴瘤患者预后更差,并表明利妥昔单抗对局限性病变疗效不佳。
J Cancer. 2019 May 12;10(9):2006-2017. doi: 10.7150/jca.29807. eCollection 2019.
3
Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia.
Bcl-2 是低倍体 B 系急性淋巴细胞白血病的治疗靶点。
Cancer Res. 2019 May 1;79(9):2339-2351. doi: 10.1158/0008-5472.CAN-18-0236. Epub 2019 Mar 12.
4
The role of aberrant proteolysis in lymphomagenesis.异常蛋白水解在淋巴瘤发生中的作用。
Curr Opin Hematol. 2015 Jul;22(4):369-78. doi: 10.1097/MOH.0000000000000156.
5
Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells.线粒体启动减少决定了结肠癌干细胞的化疗耐药性。
Cell Death Differ. 2014 Jul;21(7):1170-7. doi: 10.1038/cdd.2014.37. Epub 2014 Mar 28.
6
Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes.异三聚体 G 蛋白与细胞凋亡:相互交汇的信号通路导致与背景相关的表型。
Curr Mol Med. 2009 Jun;9(5):527-45. doi: 10.2174/156652409788488784.
7
Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes.癌症微阵列数据的跨平台分析改进了基于基因表达的表型分类。
BMC Bioinformatics. 2005 Nov 4;6:265. doi: 10.1186/1471-2105-6-265.
8
Detection of bcl-2 and bax expression and bcl-2/JH fusion gene in intrahepatic cholangiocarcinoma.肝内胆管癌中bcl-2和bax表达及bcl-2/JH融合基因的检测
World J Gastroenterol. 2004 Nov 15;10(22):3251-4. doi: 10.3748/wjg.v10.i22.3251.
9
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis.Bcl-2作为肺癌生存预后因素的作用:一项文献系统综述及荟萃分析
Br J Cancer. 2003 Jul 7;89(1):55-64. doi: 10.1038/sj.bjc.6601095.
10
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.原发性纵隔B细胞淋巴瘤:BCL-6突变频率高,且在无免疫球蛋白的情况下转录因子OCT-2、BOB.1和PU.1持续表达。
Am J Pathol. 2003 Jan;162(1):243-53. doi: 10.1016/s0002-9440(10)63815-1.